Dealing with the Challenges of a Vacation Following My Lung Transplant
I recently returned from a three-week vacation in Europe. On the trip, my wife, Rebecca, and I visited Poland, Italy, Greece, and Austria. I ... Read more
Updates
-
-
IPF Patients Older Than 75 More Likely to Stop Taking Esbriet Because of Adverse Reactions, Japanese Study Suggests
Patients older than 75 with idiopathic pulmonary fibrosis (IPF) are at higher risk of discontinuing treatment with Esbriet (pirfenidone) due to adverse reactions, namely ... Read more -
Gilead Sciences Gains Rights to GLPG1690 Clinical Program in 10-year Research Collaboration
Gilead Sciences gained rights over GLPG1690, Galapagos‘ investigational therapy for idiopathic pulmonary fibrosis (IPF), as part of a 10-year research collaboration between the two ... Read more -
5 Hospital Professionals I Couldn’t Be Without on My PF Journey
No one really enjoys being admitted to the hospital, but for many patients living with a chronic illness, hospitalization is inevitable, and can bring ... Read more -
IPF Patients in Spain, Other Countries Share Similar Characteristics to Allow Comparison and Pooling, Study Suggests
The demographic and clinical characteristics of patients with idiopathic pulmonary fibrosis (IPF) in Spain are similar to those of IPF patients in other ... Read more
-
Adopting Good Habits to Preserve Health Following Transplant
Organ transplants are a trade-off. The patient receives a healthy organ or organs, but ... -
Grant Will Help Researchers Study Mining Dusts’ Role in Lung Fibrosis
The Alpha Foundation for the Improvement of Mining Safety and Health has granted $750,000 ... -
Making Decisions with Our Health in Mind
At some point in our lives, we’re all likely to face difficult decisions. They ... -
Hypoxia is Involved in the Development and Progression of IPF, Study Suggests
Lack of tissue oxygenation, also known as hypoxia, is involved in the development and ... -
Algernon’s Investigational Anti-fibrotic, NP-120, Surpasses Esbriet, Ofev in Reducing Scarred Tissue in IPF Mice
NP-120, Algernon Pharmaceuticals‘ repurposed lead candidate for the treatment of idiopathic pulmonary fibrosis (IPF), ... -
The Assistance Fund Opens New IPF Copay Program to Help Patients with Treatment Expenses
The Assistance Fund, an independent and charitable foundation, announced that it has launched a ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests
News
Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more